Compounds > deferoxamine

deferoxamine and euk-134

deferoxamine has been researched along with euk-134 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brooks, TC; Chen, A; Fu, Y; Lowery-Nordberg, M; Manuszak, RP; Sequeira, AP; Shackelford, RE; Wang, S1
Chandel, NS; Ciechanover, A; Dada, LA; Iwai, K; Lecuona, E; Sznajder, JI; Zhou, G1
Bojadzic, D; Digruccio, MR; Leach, E; Lee, J; Nelson, MT; Orestes, P; Salajegheh, R; Todorovic, SM1

Other Studies

3 other study(ies) available for deferoxamine and euk-134

ArticleYear
Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells.
    DNA repair, 2006, Nov-08, Volume: 5, Issue:11

    Topics: Antibodies; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Catechin; Cell Culture Techniques; Cell Cycle Proteins; Cell Line; Chromosome Breakage; Deferoxamine; DNA-Binding Proteins; Drug Synergism; Humans; Iron; Iron Chelating Agents; Mutagens; Organometallic Compounds; Protein Serine-Threonine Kinases; Receptors, Transferrin; Recombinant Fusion Proteins; Salicylates; tert-Butylhydroperoxide; Thioctic Acid; Tumor Suppressor Proteins

2006
Hypoxia-mediated Na-K-ATPase degradation requires von Hippel Lindau protein.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:5

    Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Membrane; Cells, Cultured; Chlorocebus aethiops; COS Cells; Deferoxamine; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Organometallic Compounds; Salicylates; Sodium-Potassium-Exchanging ATPase; Von Hippel-Lindau Tumor Suppressor Protein

2008
Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway.
    The Journal of physiology, 2011, Jan-01, Volume: 589, Issue:Pt 1

    Topics: Adrenochrome; Analgesics, Non-Narcotic; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Catalase; Chelating Agents; Deferoxamine; Disease Models, Animal; Female; Ganglia, Spinal; HEK293 Cells; Histidine; Humans; Hydrogen Peroxide; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; Nitrous Oxide; Organometallic Compounds; Oxidation-Reduction; Pain; Pentetic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salicylates; Signal Transduction; Time Factors; Transfection

2011